Atara Biotherapeutics, Inc. (ATRA) vs Rallybio Corporation (RLYB)
Atara Biotherapeutics, Inc. and Rallybio Corporation are both Biotechnology companies. Atara Biotherapeutics, Inc. and Rallybio Corporation are of similar size ($88.2M and $85.7M). Atara Biotherapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Rallybio Corporation trades at 2.1×. Rallybio Corporation grew revenue faster over the last twelve months: 1.18% against −96.7%. Rallybio Corporation has the higher net margin (0.00% vs −269.4%) and the lower return on invested capital (−1,052.0% vs 0.00%). Across the 15 metrics below, Rallybio Corporation leads on 11 and Atara Biotherapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ATRA | RLYB | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 100.00% | 65.16% |
| Operating margin | (229.67%) | 0.00% | 0.00% |
| Net margin | (269.42%) | 0.00% | 0.00% |
| Free cash flow margin | (353.49%) | 0.00% | 0.00% |
| Return on equity | 46.33% | 64.86% | (57.72%) |
| Return on assets | (57.62%) | 61.12% | (49.22%) |
| Return on invested capital | 0.00% | (1,052.03%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack